The real-time polymerase chain reaction (PCR) technique is a useful tool when studying viral agents, and the method helps to clarify disputed infectious disease processes. A novel real-time primer design called Light-Upon Extension (LUX) has recently been introduced for viral gene detection. The system has been applied for the specific amplification of several human viral agents: noroviruses, 1 quantitative measurements of HIV-1, 2 as well as in veterinary research including Newcastle disease virus and avian influenza viruses. 3 According to the obtained results, the technique is even more sensitive than TaqMan real-time PCR technology.
The generation of a signal in LUX real-time PCR is based on a single fluorescent dye molecule attached to an oligonucleotide close to its 3′ end. 4 No quencher dye is required as a tail of 5-7 nucleotides is added to the 5′ end of the primer complementary to its 3′ end, so a blunt end hairpin can be formed. When it is not incorporated into the PCR product, this particular design of the primer provides a low initial fluorescence that may increase upon formation of the PCR product. The hairpin oligonucleotides are as efficient as linear primers and provide additional specificity to the PCR by preventing primer dimers and mispriming. They could be designed by specialized software on a set of rules for optimum signal development and could also be used for gene quantitation. Self-quenched primers are an efficient and cost-effective alternative to fluorescence resonance energy transfer-labelled oligonucleotides. 4, 5 Human papillomavirus (HPV) plays an important role in the pathogenesis of premalignant cervical lesions and cervical cancer. The most common oncogenic HPV type in cervical cancer is HPV type 16 (HPV 16), which is detectable in more than 50% of the cases. 6 Laboratory diagnosis of HPV infection is dependent upon molecular techniques such as DNA hybridization or nucleic acid amplification. Several PCR systems have been developed to detect a broad spectrum of HPV types using various primer sets. 7 As far as we know, LUX technology based systems for HPV have not been described in the literature thus far.
BKV and JC (JCV) are highly seroprevalent human viruses that, following primary infection, remain latent in various tissues and organs, including the kidney and brain. 8 Accurate and timely identification of BK and/or JC virus reactivation and a subsequent monitoring of the viral load will have a prognostic value in particular patient groups. 9 Such are immune deficiency patients either with drug (after renal transplantation) or virus-induced (HIV) impairment. Routine real-time PCR systems have not been established, and novel assays are put to the test. 10 Our objective was to design LUX real-time PCR primer systems for HPV, BKV, and JCV. Tests for the specificity of the designed primers and optimization of the reaction conditions were performed so reliable interpretation of the results and monitoring of the patients with cervical pre-cancers (HPV), kidney allograft (BKV), and progressive multifocal leukoencephalopathy (JCV) can be achieved.
Materials and Methods
Primer Design Software D-LUX designer software was used to design HPV, BKV, and JCV fluorogenic primers. The technique requires the input of the viral complete or partial genome sequence by its GenBank accession number. Several parameters can be determined in generating the labelled primers, such as the amplicon size, GC content, desired target genome region, etc. When the primer set design is complete, a report is generated with detailed information for each primer pair. The chosen sequences for synthesis were named HPLux16-1/2, BKLux-1/2, and JCLux-1/2, respectively.
Abstract
Background: Real-time polymerase chain reaction (PCR) assays for quantitative detection and typing of viruses are fast, simple, and provide valuable information about the progression of an infection. Identification of human papilloma and polyomaviruses is used to estimate the risk of cancer (papilloma), polyomavirus-associated-nephropathy (BKV), or progressive multifocal leukoencephalopathy (JCV) in individual patients. Thus, non-invasive and specific diagnostics for viral detection should be regarded.
Methods:
We describe the design, optimization, and application of effective LightUpon Extension (LUX) real-time PCR systems for detection of papillomaviruses, BKV, and JCV. Viral and human controls along with clinical samples were examined during the optimization process. D-LUX designer software and the Opticon 2 Real-Time System (Bio-Rad, Hercules, CA) were used.
Results:
We confirm the specificity, rapidity, and non-invasiveness of the method for demonstration of ongoing replication. We believe LUX technology is comparable to probe based real-time PCR assays for the detection of viruses, but it has an advantage in terms of cost-effectiveness, convenience, and possibility for a dissociation analysis. 11 were taken. All experiments were repeated 3 times, and all 3 results were used separately in statistical analysis.
Conclusions

Controls and Human Clinical Samples
The tests for optimization for the different assays included 15 controls that were HPV type 16 positive, 7 more for BKV, and 1 control sample for JC, altogether with template free controls. In addition, specificity tests were run with viral and bacterial DNAs that were used as negative control samples, with a total number of 18 with HPV; 8 with BKV; and 4 with JCV.
Positive controls, DNA from SiHa, and/or CaSki cell lines, naturally infected with HPV-16 12 and previously verified HPV-16 positive cervical samples 13 (n=14) were tested with HPLux16 primers. In parallel, negative controls including cervical samples from women with normal cytological results (n=6); samples verified as HPV positive for genotypes 6, 11, and 18 (n=6); heterologous DNA, and distilled water, were used in each lot of specimens and tested with different virus-specific primer sets. The heterologous DNA was obtained from several common pathogens including viruses (Herpes simplex virus 1, Herpes simplex virus 2, Hepatitis B virus, Human immunodeficiency virus type 1), and bacteria (Neisseria gonorrhoeae and Chlamydia trachomatis).
BKV DNA previously evaluated from urine and serum samples of a patient, which developed BK-associated nephropathy (BKAN), and BKV positive urine samples (n=5) from renal allograft patients were used as positive controls for BK LUX primers. All urine samples were collected as fresh morning samples in sterile containers (Biologix, Lenexa, KS) with anti-bacterial buffer (50 mg/l Gentamycin sulfate; 20 mg/l Amphotericin-B) and absolute ethanol as a preservative for transportation to the laboratory. To ensure specific BK virus amplification, related (Simian Virus 40 genome, JC virus DNA) and distant (HPV 16, 18, and Herpes simplex virus) viral genomes as well as normal human urothelial DNA (n=3) were also included in the optimization protocol.
Brain biopsy derived DNA from a patient with post mortem histopathological conformation of PML was used as a positive control in all optimization procedures. The sample was obtained from formalin-fixed material. In addition, CSF samples (n=10) from people with neurological disorders, which were considered PML possible cases, were tested to verify the application of the detection system in the clinical practice. Polyomavirus BK, SV-40, HPV 16, and human herpes virus 1 DNA were also tested to exclude non-specific amplification. Additionally, a template free control was included in each run.
In total, 47 clinical samples previously specified by different assays were tested for verification of the LUX primer systems.
The specimens included cervical swabs (n=26) tested for and HPV genotyped with a conventional PCR system (Sacace Biotechnologies, Como, Italy). BKV was identified from urine samples (n=6) and a serum by 2 other real-time systems that were probe based (PrimerDesign, Southampton, United Kingdom; Liferiver, Shanghai, China). JCV was additionally documented with a Taqman assay (PrimerDesign) and an inlab modified SYBR Green system. 14 The clinical specimens used for testing were taken by the attending specialist, stored at 4-8ºC for not more than 6 hours or at -20ºC for a maximal period of 48 hours and transported with an IsoTherm System (Eppendorf, Hamburg, Germany). After delivery at the laboratory, the samples were either processed immediately or stored at -70ºC before DNA extraction.
The specificity of the LUX real-time PCR product was determined by comparing the obtained specific melting curves for HPV, BKV, and JCV DNAs, and the other viral or human controls. In order to prove the efficacy of the extraction protocols and the absence of inhibitory substances in the extracted material, a primer set PCO3/PCO4 (specific for human β-globin gene amplification) was used. 15 All manipulations were performed according to biosafety requirements.
DNA Extraction Procedures
An Aqua Pure Genomic DNA Isolation Kit (Bio-Rad) was used for the isolation of DNA from the solid tissue sample, according to the manufacturer's recommendations. Quality and quantity of the extracted nucleic acid was assessed both with a spectrophotometer and an agarose gel electrophoresis. CSF, serum, and urine DNA was extracted, purified, and concentrated employing QIAamp DNA Mini Kit (Quiagen, Hilden, Germany) following the supplier's instructions.
Results
Design and Evaluation of LUX Primers for HPV-16
We designed and proved the effectiveness of the LUX primers for the detection of HPV-16, 1 of the highest oncogenic genotypes, using nucleotide sequences in the HPV-16 genome. The fluorogenic foreword primer was marked with FAM (6-carboxyfluorsecin). Obtained oligos were analyzed for their specificity using the NCBI Blast Software which did not reveal significant similarities with other sequences. Nucleotide sequences of the primer pairs were synthesized and marked by Invitrogen. Designed sequences and their flanked genome section on the E6/HPV-16 are presented below:
(HPV-16 E6 nt 74)
CGGTCGATGTATGTCTTGTTGCAGATCATCAA-GAACACGTAGAGAAACCCAGCTGTAATCATGCAT-GGAGATACACCTACATTGCATGAATATATGTTA-GATTTGCAACCAGAGACAACTGATCT (HPV-16 E6 nt 626◀); amplicon size: 550 bp.
The optimized HPV-16 amplification protocol for a total reaction volume of 50 µL consisted of the following steps: 95ºC/10 minutes (1 cycle); 50 cycles at 95ºC/15 seconds, 60ºC/1 minute, and a plate read at the end of each annealing/ extension step.
Specificity and sensitivity of the LUX-primers for the detection and typing of HPV-16 were studied using real-time PCR and a set of control DNA, extracted from different viruses, bacteria, chlamydia, and clinical HPV positive and negative samples from different origins (Figure 1) as already described. The LUX assay detected HPV 16 sequences from SiHa and/or CaSki cell lines with a concentration as low as 10 fg.
Two of the HPV 16 control specimens were also determined as HPV 18 positive with a conventional multiplex PCR system (Sacace Biotechnologies). The tested samples showed an increase in the signal during the amplification with the LUX primer assay, and the following melting curve analysis revealed a characteristic HPV 16 pattern (Tm=80°C). In contrast, 2 specimens that were HPV 18 positive were documented as negative.
Primer Design and Characteristics of LUX-Primers for BKV
LUX-fluorogenic primers were designed from the genome of BK virus strain Dunlop available in the GeneBank with accession number V01108. Out of 15 displayed oligonucleotide sequences, those with the best properties were targeted for the specific genomic region of the small t antigen. They were named BKLux-1 and BKLux-2 and used for further analysis. For additional insurance of their specificity, a nucleotide blast for short sequences was performed (BLAST). A 100% similarity was found only with the BKV strain J3B-3. No similarities with other polyomaviruses/viruses were observed. The oligonucleotides flanked a genomic region of the small t antigen of the BK virus genome (Strain Dunlop). The flanked region of 51 bp is presented, where the primer sequences are listed in bold, and their characteristics are shown in Table 1 .
4621 ataagttagt taccttaaag ctttagatct ctgaagggag tttctccaat tatttggacc 4681 caccattgca gagtttcttc agttaggtct aagccaaacc actgtgtgaa gcagtcaatg 4741 cagtagcaat ctatccaaac caagggctct tttcttaaaa attttctatt taaatgcctt 4801 aatctaagct gacatagcat gcaagggcag tgcacagaag gctttttgga acaaataggc 4861 cattccttgc agtacagggt atctgggcaa agaggaaaat cagcacaaac ctctgagcta 4921 ctccaggttc caaaatcagg ctgatgagct acctttacat cctgctccat ttttttatac 4981 aaagtattca ttctcttcat tttatcctcg tcgccccctt tgtcagggtg aaattcctta 5041 cacttcctta aataagcttt tctcattaag ggaagatttc cccaggcagc tctttcaagg 5101 cctaaaaggt ccatgagctc catggattct tccctgttaa gaactttatc cat
The BKV-LUX PCR reaction protocol included the following: initial denaturation at 95°C for 10 minutes, followed by 45 cycles consisting of denaturation at 95°C (15 seconds), and 1 step of annealing/elongation at 60°C (1 minute). Fluorescence spectra were recorded during the annealing/elongation phase of each PCR cycle. The cycle threshold was calculated as the cycle number at which the reaction became exponential. The sensitivity of the assay was determined to be approximately 100 copies per test tube.
In order to evaluate the specificity of the BKV amplification, different viral genomes and DNAs were included in the optimization reactions. The control BK virus, obtained from urine, became positive at the 11th cycle, which was considered a threshold cycle (Ct=12) and BK virus DNA from sera was detected at the 37th (Ct=38) (Figure 2A) . No increase in fluorescence spectra was observed in the other closely related and distant viral genomes as well as the human DNA.
To identify the specific PCR products generated at the presence of LUX primers, Tm analysis was performed by increasing the temperature from 60°C to 95°C at a transition rate of 0.2°C/s. The software calculated the Tm, (ie, the rate of change of fluorescence [Tm=-dI/dT]) and was displayed as a function of temperature. The melting curve analysis of the BKV PCR product revealed a maximum peak at ~78.0°C corresponding to the increase of the fluorescence of BKV DNA controls (urine, sera) above the threshold. No melting peaks were observed in the rest of the DNA samples ( Figure 2B) . The size of the amplified product (51 bp) was verified also by gel-electrophoresis (data not shown).
Primer Design and Characteristics of LUX-Primers for JCV
LUX primer sets were designed and targeted at the genome of JC virus available in the GenBank with accession number J02226. Of all designed oligonucleotide sequences, 5 with the best properties were selected and synthesized (Invitrogen). These were tested, and 1 primer pair termed JCLux 1/2 was determined as the most promising and used for further analysis. A 100% similarity in BLAST analysis was found only with different JCV strains. No similarities with other polyomaviruses/viruses or human genomic DNA were observed.
After optimization, a distinct fluorescent signal with the earliest threshold cycle (Ct=25) and best dissociation analysis profile was seen with an annealing/extension temperature of 63.0°C (Figure 3) . The reaction protocol included the following: initial denaturation at 95°C for 10 minutes, followed by 40 cycles consisting of denaturation at 94°C (15 seconds), and 1-step of annealing/elongation at 63°C (1 minute). The melting curve post PCR analysis was done in a similar manner as described above for BKV. The melting curve temperature of the JCV PCR product was ~78.4°C. Lack of specific increase in the fluorescent signal and no distinguished melting peaks were observed in the CSF samples from people with other neurological disorders or with polyomavirus BK, SV-40, HPV 16 and 18, human herpes virus 1 DNA, and in a template free control (Figure 4) . The limit of the assay was set as low as 100 JCV genomic copies per reaction.
Discussion
LUX real-time PCR primer systems were used for rapid detection of human papilloma and polyomaviruses. Unlike the real-time PCR assays using probes (TaqMan PCR), the LUX-based technology is functionally simplified. It requires the use of a specific pair of primers, of which only 1 primer is labelled. The fluorogenic primer method has several advantages over other methods including ease of design of the primers. The design is based on studies demonstrating the effects of the primary and secondary structure of oligonucleotides on the emission properties of a conjugated fluorophore. The primers are chemically synthesized oligonucleotides (22-29 nt in length) with a fluorophore attached to the C5 position of thymidine, which increases its fluorescence when incorporated into the double-stranded PCR product. This phenomenon results from several important facts: (a) having the fluorophore close to the 3′-end of an oligonucleotide with G or C at the end, (b) the existence of a G within a few bases of the label, and (c) the ability of the oligonucleotide to form a bluntended hairpin at temperatures close to the annealing temperatures of the primer. 5 Therefore, no quencher is needed as the specific conformation of the labelled primer suppresses the emission of the dye. When specific hybridization occurs, followed by sequence extension, the intensity of the fluorescent signal increases dramatically due to the lack of conformational inhibition. We believe this technology is suitable for routine laboratory diagnostics. In addition, LUX real-time PCR can lower the performance cost of real-time PCR-based research. 16 The developed new approach to PCR-based detection of microorganisms uses genomic sequences to find speciesspecific regions for design of PCR primers targeted to these sequences. Such species or group-specific repeats can increase the sensitivity of detection. One advantage of the method is that it allows different phylogenetic groups to be handled automatically-microbial genera, group of species, or group of strains. Thus, the method introduced here offers a universal approach to designing taxon-specific PCR primers. Another advantage is that annotations of target and non-target organism genomes are not required, in contrast to certain other approaches. [17] [18] [19] [20] Thus, the methodology and software described here should be suitable for designing both conventional and real-time PCR primers.
The developed real-time assay for the detection of HPV-16 was demonstrated to be highly specific and able to detect its targeted sequence even when HPV 18 is present in the same sample. Theoretically, it is possible to perform multiplex LUX-PCR for simultaneous identification of 2 different targets as primers, which might be labeled with FAM or JOE (6-carboxy-4′, 5′-dichloro-2′, 7′-dimethoxyfluorescein). These dyes have an emission spectra at different wavelengths, and therefore, their signals can be detected simultaneously in 2 detection channels. However, in our study we did not try to perform such an analysis. As the HPV 16 LUX assay is very sensitive and specific, it can be used when monitoring the status of patients with previously determined HPV 16 positive results.
It was demonstrated that the designed BK virus LUX primer pair is a specific and reliable tool for detecting ongoing BK virus replication. This was confirmed not only by the increase of fluorescence emission of the positive BKV control DNA from serum and urine, but also by melting curve analysis performed and the demonstration of a single peak at ~78.0°C. The reaction could be applied in the diagnosis and routine screening for BK virus replication in renal-allograft patients.
When JC sequences are detected in CSF, the diagnosis of a possible PML case has its laboratory conformation, which is considered sufficient for this disorder. 21 These results indicate that the JC LUX system can be readily introduced in support of the clinicians. Additionally, the qualitative system can be easily transformed to a quantitative 1 as viral standards with a known amount of starting copies are only required. We believe that the application of a quantitative LUX real-time PCR can benefit from the monitoring of the disease progression and might be of use when a prognosis is determined. Moreover, the detection of polyomavirus genomic sequences can be employed in studies concerning the associations of these viruses with human malignancies.
Overall, the determined sensitivity and specificity of the designed LUX assays were comparable to those used for initial detection and genotyping. The active viral infection is by rule demonstrated by a relatively high viral production, and most real-time systems are able to detect even very low loads. The study documented the limit of each assay to be, as expected, in the range of 100-300 starting copies. We consider this sufficient for the sake of detection and monitoring the state of the described pathogens.
In conclusion, the fluorogenic primer method (LUX) is rapid, uses few toxic chemicals, and is useful for the specific and accurate detection of viral DNA among different types of samples. However, further studies should be performed in order to establish a diagnostic agreement with other available real-time methods in the field of clinical purpose detection. LM Figure 4_ (A) Amplification plot of the JC virus DNA and other viral or human genome template DNA. 1. JC virus positive amplification from brain biopsy (Ct=23) of a PML confirmed case; 2. Positive amplification in CSF from a patient with a PML possible case (Ct=26); 3. Negative amplification controls (below the threshold). (B) Melting curve analysis of the PCR products of the samples described above with Tm ~ 78.4°C (-dI/dT=78.4) and no melting peak in the negative control genomes or template free sample.
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